FDA Approves Merck's LIPFENDRA Tablets To Reduce Cholesterol In Adults
MRK•FDA approval for LIPFENDRA tablets
July 16 (Reuters) - Merck & Co Inc MRK.N:
- MERCK: FDA APPROVES LIPFENDRA TABLETS 20 MG TO REDUCE LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN ADULTS WITH HYPERCHOLESTEROLEMIA
